Biochemical and Biophysical Research Communications
siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme☆,☆☆
Section snippets
Materials and methods
siRNA and DNA-vector based expressing siRNA preparation. The targeted region of siRNA was the coding sequence of SOD1 cDNA. The 5′ or 3′ UTRs and regions nearby the start codon are avoided, as these may be richer in regulatory protein binding sites. siRNA sequences of the form AA N19–20 and CA N19–20 with GC content less than 70% were selected from this region [9]. Next, the nucleotide preference after AA/CA is G or A, because it is required for efficient RNA polymerase initiation. Selected 19-
siRNA and expressing siRNA for G93A SOD1
Two siRNAs targeting G93A SOD1 corresponding to regions 277–297 (siRNA G93A.1) and 275–294 (siRNA G93A.2) were designed (Fig. 1A). Transfection of both siRNAs into mammalian cells could effectively reduce G93A SOD1 expression. Western blot analysis revealed that both siRNA G93A.1 and 2 reduced the expression of G93A SOD1 protein by about 90% when expression efficiency was adjusted with co-transfected GFP (Fig. 1B). The suppression of G93A SOD1 protein by siRNA G93A.1 increased in a
Discussion
In autosomal dominant disease, such as familial ALS, the most effective therapeutic approach requires the reduction of the aberrant mutant protein leaving wild-type protein intact. Possible candidate methods include ribozyme, DNA enzyme, and siRNA to cleave mutant RNA selectively. Antisense RNA or DNA has been used to reduce the expression of target protein, but these do not discriminate between the wild-type and mutant mRNA of SOD1, most of which has a point mutation [15]. siRNA G93A.1 and 2,
Acknowledgements
The authors thank Alyson Peel, Ph.D., Dr. Li Yi, Dr. Hiroki Sasaguri. and Dr. Yuki Saito for their help. This study was supported by Grants from the National Institutes of Health (NS35155 to D.E.B.) and the ALS Association, the Ministry of Education, Science and Culture, Japan (A-130, T.Y.), from the Ministry of Health, Labor and Welfare, Japan (T.Y., H.M.), and from Japan Amyotrophic Lateral Sclerosis Association (T.Y.).
References (24)
- et al.
A method for generating transcripts with defined 5′ and 3′ termini by autolytic processing
Gene
(1992) - et al.
A method for determining the cytoprotective effect of catalase in transiently transfected cell lines and in corneal tissue
Anal. Biochem.
(1999) - et al.
Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosome
Chem. Biol.
(1999) - et al.
Mutations in Cu, Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis
Nature
(1993) From Charcot to SOD1: mechanisms of selective motor neuron death in ALS
Neuron
(1983)- et al.
Mechanisms of antiviral action of interferon
Interferon
(1999) Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation
Biochem. Soc. Trans.
(1997)- et al.
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Nature
(2001) - et al.
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate
EMBO J.
(2001) - et al.
The sequence requirements of the hammerhead self-cleavage reaction
Biochemistry
(1990)
A general purpose RNA-cleaving DNA enzyme
Proc. Natl. Acad. Sci. USA
RNA interference
Genes Dev.
Cited by (0)
- ☆
Abbreviations: ALS, amyotrophic lateral sclerosis; SOD, superoxide dismutase; siRNA, small interfering RNA; dsRNA, double-stranded RNA; rAAVs, recombinant adeno-associated viruses.
- ☆☆
Supplementary data associated with this article can be found, in the online version, at doi:10.1016/j.bbrc.2003.12.098.